Jeffrey R. Idle
- Pharmacology top 0.01%
- Molecular Biology top 0.5%
- Oncology top 0.5%
- Cancer Research top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Co-authors
- Frank J. GonzalezRichard L. SmithKristopher W. KrauszAnn K. DalyA. MahgoubDiren BeyoğluS. CholertonAndrew D. Patterson
- Topics
- Pharmacogenetics and Drug Metabolism (103 papers)Metabolomics and Mass Spectrometry Studies (49 papers)Drug Transport and Resistance Mechanisms (32 papers)
- Cited by
- PharmacologyBiochemistryOncology
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Jeffrey R. Idle
270 papers receiving 15.1k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Pharmacology 6.4k
- Molecular Biology 6.4k
- Oncology 3.3k
- Cancer Research 1.7k
- Pediatrics, Perinatology and Child Health 1.4k
Countries citing papers authored by Jeffrey R. Idle
This map shows the geographic impact of Jeffrey R. Idle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey R. Idle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey R. Idle more than expected).
Fields of papers citing papers by Jeffrey R. Idle
This network shows the impact of papers produced by Jeffrey R. Idle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey R. Idle. The network helps show where Jeffrey R. Idle may publish in the future.
Co-authorship network of co-authors of Jeffrey R. Idle
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey R. Idle. A scholar is included among the top collaborators of Jeffrey R. Idle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey R. Idle. Jeffrey R. Idle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 9 | |
| 6 | 142 | |
| 7 | 44 | |
| 8 | 224 | |
| 9 | 16 | |
| 10 | 48 | |
| 11 | Christmas gingerbread (Lebkuchen) and Christmas cheer--review of the potential role of mood elevating amphetamine-like compounds formed in vivo and in furno. | 2 |
| 12 | 12 | |
| 13 | 113 | |
| 14 | Correspondence re: S. J. London et al., Lung Cancer Risk in African-Americans in Relation to a Race-specific CYP1A1 Polymorphism. Cancer Res., 55: 6035–6037, 1995. — Reply | 12 |
| 15 | 6 | |
| 16 | 148 | |
| 17 | The preeminence of nicotine n oxidation and its diminution after carbimazole administration | 7 |
| 18 | 14 | |
| 19 | 26 | |
| 20 | 92 |
About Jeffrey R. Idle
Jeffrey R. Idle is a scholar working on Pharmacology, Biochemistry and Clinical Biochemistry, having authored 270 papers that have together received 15.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (103 papers), Metabolomics and Mass Spectrometry Studies (49 papers) and Drug Transport and Resistance Mechanisms (32 papers). The work is most often cited by research in Pharmacology (6.4k citations), Biochemistry (995 citations) and Oncology (3.3k citations). Jeffrey R. Idle has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Frank J. Gonzalez, Richard L. Smith, Kristopher W. Krausz, Ann K. Daly, A. Mahgoub, Diren Beyoğlu, S. Cholerton, Andrew D. Patterson, Richard Lancaster and Xiaochao Ma. Their work appears in journals such as Nature, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.